Chimpharm announces decisions of Board of Directors on concluding major transaction and interested party transactions

/KASE, November 3, 2017/ – Chimpharm (Shymkent), whose shares are officially listed on Kazakhstan Stock Exchange (KASE), has notified KASE of decisions of its Board of Directors dated November 1, 2017 (in Kazakh and Russian) – http://www.kase.kz/files/emitters/CHFM/chfm_info_reshenie_sd_011117_1701.pdf [2017-11-03]